A+ A A-

What's New

New to Portal

  • ASM is a supporter of National Medical Laboratory Professionals Week (NMLPW). NMLPW provides the profession with a unique opportunity to increase...

  • Demonstrate expertise in medical and public health microbiology with ABMM certification; application deadline April 1.

  • The February Hot Topic discussion, "New Drugs: Few Tests" , was presented by Romney Humphries, Ph.D., D(ABMM), Section Chief, Clinical Microbiology, UCLA...

  • CDC launches the Antibiotic Resistance Laboratory Network:To better detect and respond to resistant organisms – learn how you can participate.

  • ASM 2017 ASM New Tech Professional Development Grant Program Application Deadline: February 15. 

ASM Updates

News Digest

Public Policy

Upcoming Events

Featured Content

  • Somalia reports 4000 cholera cases since beginning of the year

    Somalia reports 4000 cholera cases since beginning of the year

    The Somalia Ministry of Health reported 913 new suspected cases of cholera, including 10 deaths and a case–fatality rate of 1.1% during the past week. This brings the total since the beginning of the year to 4026 cumulative suspected cases of cholera including 57 deaths (case–fatality rate 1.5%).

  • Influenza update - 282

    Influenza update - 282

    Influenza activity in the temperate zone of the northern hemisphere continued to increase, with many countries especially in East Asia and Europe having passed their seasonal threshold early in comparison with previous years

  • Toward Killing Cancer with Bacteria

    Toward Killing Cancer with Bacteria

    Researchers employ an engineered microbe to destroy tumor cells in mice.

  • New AST Webinars Starting in March

    New AST Webinars Starting in March

    These P.A.C.E. ®-accredited webinars provide a thorough coverage of key issues encountered when performing antimicrobial susceptibility testing (AST) within the clinical laboratory.

topics 10072014 qa 10072014 cumitechs 10072014 


American Society For Microbiology © 2017 | Privacy Policy | Terms of Use